Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q3 2022 -Results Earnings Call TranscriptSeeking Alpha • 11/08/22
Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/07/22
Why Atea Pharmaceuticals (AVIR) Might Surprise This Earnings SeasonZacks Investment Research • 11/04/22
Atea Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call on November 7, 2022GlobeNewsWire • 10/31/22
Atea to Advance Global Phase 3 Registrational Study of Bemnifosbuvir in High-Risk Non-Hospitalized Patients with COVID-19GlobeNewsWire • 09/13/22
Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/08/22
Atea Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call on August 8, 2022GlobeNewsWire • 08/01/22
Atea Pharmaceuticals, Inc. (AVIR) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/13/22
Atea Pharmaceuticals Participates in the William Blair Biotech Focus ConferenceGlobeNewsWire • 07/11/22
Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/10/22
Atea Pharmaceuticals Reports Nonclinical Bemnifosbuvir (AT-527) Toxicology Data at Society of Toxicology 61st Annual MeetingGlobeNewsWire • 03/28/22
Atea Pharmaceuticals, Inc. (AVIR) Surges 7.4%: Is This an Indication of Further Gains?Zacks Investment Research • 03/21/22
Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Zoom Reports Slowing Growth, but This Stock Is Monday's Real After-Hours WinnerThe Motley Fool • 03/01/22
Dow Jones Newswires: Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advancesMarket Watch • 02/28/22
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 02/28/22
Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/09/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea Pharmaceuticals, Inc. - AVIRNewsfile Corp • 02/03/22
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Atea Pharmaceuticals, Inc. (AVIR) InvestigationBusiness Wire • 01/12/22
Atea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/22